查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美放射性示踪劑市場預測至 2030 年 - 區域分析 - 按示踪劑類型、測試類型、應用和最終用戶
市場調查報告書
商品編碼
1420159

北美放射性示踪劑市場預測至 2030 年 - 區域分析 - 按示踪劑類型、測試類型、應用和最終用戶

North America Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type, Test Type, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 112 Pages | 訂單完成後即時交付

價格

2022年北美放射性示蹤劑市值為813916萬美元，預計2030年將達到2933101萬美元；預計2022年至2030年CAGR為17.4%。

擴大使用核成像技術推動了北美接髮市場

PET 和 SPECT 屬於臨床環境中使用的核子醫學放射學方法。由於它們可以準確地檢測、定位和表徵疾病，因此它們的使用正在增加。用於診斷和治療的電離輻射使全球數百萬患者受益。醫學中的放射有助於早期診斷，並且通常為人類疾病提供侵入性較小的治療方法。先進的放射技術為診斷和核子醫學、放射治療和介入放射學開闢了新的視野。根據世界衛生組織統計，每年進行超過 36 億次放射診斷檢查、3,700 萬次核醫手術、750 萬次放射治療。用於PET/CT 和SPECT/CT 程序的新型放射性藥物的開發和推出，用於神經病學和骨科等新型臨床應用，以及不同腫瘤分期方法的準確性不斷提高，有助於放射性示踪劑市場的成長。例如，新推出的心臟放射性藥物（如氟吡達茲 F-18 和氨 N-13）有助於更精確地對心血管疾病進行成像。因此，提高核子造影技術品質和功效的持續技術進步有利於放射性示蹤劑市場的成長。

北美放射性示蹤劑市場概況

北美放射性示蹤劑市場分為美國、加拿大和墨西哥。 2022年，美國在北美放射性示蹤劑市場中佔據最大佔有率。患有慢性病和病毒性疾病的患者數量不斷增加，先進診斷方法的研發活動不斷增加，是推動放射性追蹤劑市場的關鍵因素。此外，核成像技術的日益使用也有利於市場的擴張。

北美放射性示蹤劑市場收入及 2030 年預測（百萬美元）

北美放射性示蹤劑市場細分

北美放射性示踪劑市場根據示踪劑類型、測試類型、最終用戶、應用和國家進行細分。根據示蹤劑類型，北美放射性示蹤劑市場分為Technetium-99m 和Tc-97m、碘-131、鐵-59、鐓-171、銣(Rb-82) 氯化物和氨(N-13)、鈧-46、seaborgium-269、hassium-269、檸檬酸鎵Ga 67、前列腺特異性膜抗原(PSMA) (Ga-68)、FDDNP (F-18) 和FDOPA (F-18)、磷-32 和鉻- 51、鉈-201、F-18 FDG、F-18 FAPI、Ga-68 FAPI、F-18 PSMA、DOTATOC/DOTANOC/DOTATATE (Ga-68) 等。 2022 年，其他細分市場佔據最大市場佔有率。

根據測試類型，北美放射性追蹤劑市場分為 PET、SPECT 等。 SPECT 細分市場在 2022 年佔據最大的市場佔有率。

根據最終用戶，北美放射性示蹤劑市場分為醫院和診所、診斷中心、學術和研究機構等。 2022 年，醫院和診所細分市場佔據最大的市場。

根據應用，北美放射性示蹤劑市場分為腫瘤學、肺病學、神經病學、心臟病學等。 2022 年，腫瘤學領域佔據最大的市場。

根據國家/地區，北美放射性示蹤劑市場分為美國、加拿大和墨西哥。 2022年，美國在北美放射性示蹤劑市場佔有率中佔據主導地位。

Rotem Industries Ltd、Invicro LLC、Cardinal Health Inc、紐卡斯爾大學、諾華公司、Curium、Blue Earth Diagnostics Limited、通用電氣公司和 IBA Radiopharma Solutions 是北美放射性示踪劑市場的一些領先參與者。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美放射性示蹤劑市場 - 主要產業動態

  • 主要市場促進因素：
    • 慢性病盛行率上升
    • 擴大使用核子成像技術
  • 市場限制
    • 放射性示蹤劑的保存期限短
    • 核診斷影像程序替代品的可用性
  • 市場機會
    • 放射性示蹤劑研發新舉措
  • 未來的趨勢
    • 放射性示蹤劑在癌症診斷的應用
  • 影響分析：

第 5 章：放射性示蹤劑市場 - 北美市場分析

  • 放射性示蹤劑市場收入，2022 - 2030

第 6 章：北美放射性示蹤劑市場 - 收入和 2030 年預測 - 按示蹤劑類型

  • 概述
  • 2022 年及 2030 年放射性示蹤劑市場收入佔有率，依示蹤劑類型分類 (%)
  • 锝 99m 和 TC-97m
  • 碘131
  • 鐵59
  • 镥- 171
  • RB82和氨N-13
  • 鈧46
  • ?-269
  • 哈西姆-269
  • 檸檬酸鎵 GA 67
  • PSMA GA68
  • FDDNP (F-18) 和 FDOPA (f-18)
  • 磷 32 和鉻 -51
  • 鉈201
  • F-18 FDG
  • F-18 FAPI
  • GA 68 FAPI
  • F-18 PSMA
  • DOTATOC/DOTANOC/DOTATATE Ga 68
  • 其他

第 7 章：北美放射性示蹤劑市場 - 收入和 2030 年預測 - 按測試類型

  • 概述
  • 2022 年及 2030 年按測試類型分類的放射性示蹤劑市場收入佔有率 (%)
  • 寵物
  • SPECT
  • 其他

第 8 章：北美放射性示蹤劑市場 - 收入和 2030 年預測 -按應用。

  • 概述
  • 2022 年和 2030 年按應用分類的放射性示蹤劑市場收入佔有率 (%)
  • 腫瘤學
  • 肺部
  • 神經病學
  • 心臟病學
  • 其他

第 9 章：北美放射性示蹤劑市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年及 2030 年最終用戶放射性示蹤劑市場收入佔有率 (%)
  • 醫院和診所
  • 診斷中心
  • 學術及研究機構
  • 其他

第 10 章：北美放射性示蹤劑市場 - 國家分析

    • 美國
    • 加拿大
    • 墨西哥

第 11 章：放射性示蹤劑市場產業格局

  • 概述
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 12 章：放射性示蹤劑市場，主要公司概況

  • Rotem Industries Ltd
  • Invicro LLC
  • Cardinal Health Inc
  • Newcastle University
  • Novartis AG
  • Curium
  • Blue Earth Diagnostics Limited
  • General Electric Co
  • IBA Radiopharma Solutions

第 13 章：附錄

  • 關於我們
  • 專業術語
Product Code: BMIRE00029121

The North America radioactive tracer market was valued at US$ 8,139.16 million in 2022 and is expected to reach US$ 29,331.01 million by 2030; it is estimated to grow at a CAGR of 17.4% from 2022 to 2030.

Increasing Use of Nuclear Imaging Techniques fuel the North America Hair Extension Market

PET and SPECT are among the nuclear medicine radiology modalities employed in clinical settings. Their use is increasing as they offer accurate detection, localization, and characterization of diseases. Ionizing radiation for diagnosis and treatment benefits millions of patients globally. Radiation in medicine helps earlier diagnosis and often offers less invasive treatments for human diseases. Advanced radiation technology has opened new horizons in diagnostic and nuclear medicine, radiotherapy, and interventional radiology. According to World Health Organization, over 3,600 million diagnostic radiology examinations are performed, 37 million nuclear medicine procedures are carried out, and 7.5 million radiotherapy treatments are given annually. The development and introduction of new radiopharmaceuticals for PET/CT and SPECT/CT procedures, which are used in novel clinical applications such as neurology and orthopedics, and the growing accuracy of different tumor staging methods contribute to the growth of the radioactive tracer market. For instance, newly introduced cardiac radiopharmaceuticals such as flurpiridaz F-18 and ammonia N-13 help in more precise imaging of cardiovascular conditions. Thus, constant technological advancements for improving the quality and efficacy of nuclear imaging techniques favor the growth of the radioactive tracer market.

North America Radioactive Tracer Market Overview

The North America radioactive tracer market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest share of the North America radioactive tracer market. Rising number of patients suffering from chronic conditions and viral diseases, increasing activities in research and development in advanced diagnosis method are the key factors propelling the market for radioactive tracer. Also, the increasing use of nuclear imaging techniques are favoring market expansion.

North America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)

North America Radioactive Tracer Market Segmentation

The North America radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the North America radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.

Based on test type, the North America radioactive tracer market is segmented into PET, SPECT, and others. The SPECT segment held the largest market share in 2022.

Based on end user, the North America radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.

Based on application, the North America radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.

Based on country, the North America radioactive tracer market is segmented into the US, Canada, and Mexico. The US dominated the North America radioactive tracer market share in 2022.

Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, Blue Earth Diagnostics Limited, General Electric Co, and IBA Radiopharma Solutions are some of the leading players operating in the North America radioactive tracer market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America radioactive tracer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America radioactive tracer market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America radioactive tracer market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Radioactive Tracer Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Rising Prevalence of Chronic Diseases
    • 4.1.2 Increasing Use of Nuclear Imaging Techniques
  • 4.2 Market Restraints
    • 4.2.1 Short Shelf-Life of Radioactive Tracer
    • 4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
  • 4.3 Market Opportunities
    • 4.3.1 New Initiatives for Radioactive Tracer R&D
  • 4.4 Future Trends
    • 4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
  • 4.5 Impact Analysis:

5. Radioactive Tracer Market - North America Market Analysis

  • 5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030

6. North America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Tracer Types

  • 6.1 Overview
  • 6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • 6.3 Technetium 99m and TC-97m
    • 6.3.1 Overview
    • 6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Iodine 131
    • 6.4.1 Overview
    • 6.4.2 Iodine 131: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Iron 59
    • 6.5.1 Overview
    • 6.5.2 Iron 59: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Lutetium- 171
    • 6.6.1 Overview
    • 6.6.2 Lutetium- 171: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 RB82 and ammonia N-13
    • 6.7.1 Overview
    • 6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Scandium 46
    • 6.8.1 Overview
    • 6.8.2 Scandium 46: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.9 Seaborgium-269
    • 6.9.1 Overview
    • 6.9.2 Seaborgium-269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.10 Hassium -269
    • 6.10.1 Overview
    • 6.10.2 Hassium -269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.11 Gallium Citrate GA 67
    • 6.11.1 Overview
    • 6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.12 PSMA GA68
    • 6.12.1 Overview
    • 6.12.2 PSMA GA68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.13 FDDNP (F-18) and FDOPA (f-18)
    • 6.13.1 Overview
    • 6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.14 Phosphorus 32 and Chromium -51
    • 6.14.1 Overview
    • 6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.15 Thallium-201
    • 6.15.1 Overview
    • 6.15.2 Thallium-201: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.16 F-18 FDG
    • 6.16.1 Overview
    • 6.16.2 F-18 FDG: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.17 F-18 FAPI
    • 6.17.1 Overview
    • 6.17.2 F-18 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.18 GA 68 FAPI
    • 6.18.1 Overview
    • 6.18.2 GA 68 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.19 F-18 PSMA
    • 6.19.1 Overview
    • 6.19.2 F-18 PSMA: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
    • 6.20.1 Overview
    • 6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.21 Others
    • 6.21.1 Overview
    • 6.21.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 PET
    • 7.3.1 Overview
    • 7.3.2 PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 SPECT
    • 7.4.1 Overview
    • 7.4.2 SPECT: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Application.

  • 8.1 Overview
  • 8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Oncology
    • 8.3.1 Overview
    • 8.3.2 Oncology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pulmonary
    • 8.4.1 Overview
    • 8.4.2 Pulmonary: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Neurology
    • 8.5.1 Overview
    • 8.5.2 Neurology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Radioactive Tracer Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Centers: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Radioactive Tracer Market - Country Analysis

  • 10.1 North America Radioactive Tracer Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America Radioactive Tracer Market, by Country
      • 10.1.2.1 US
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 US Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 US Radioactive Tracer Market, by Tracer Types
        • 10.1.2.1.4 US Radioactive Tracer Market, by Test Type
        • 10.1.2.1.5 US Radioactive Tracer Market, by Application
        • 10.1.2.1.6 US Radioactive Tracer Market, by End-User
      • 10.1.2.2 Canada
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Canada Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Canada Radioactive Tracer Market, by Tracer Types
        • 10.1.2.2.4 Canada Radioactive Tracer Market, by Test Type
        • 10.1.2.2.5 Canada Radioactive Tracer Market, by Application
        • 10.1.2.2.6 Canada Radioactive Tracer Market, by End-User
      • 10.1.2.3 Mexico
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Mexico Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 Mexico Radioactive Tracer Market, by Tracer Types
        • 10.1.2.3.4 Mexico Radioactive Tracer Market, by Test Type
        • 10.1.2.3.5 Mexico Radioactive Tracer Market, by Application
        • 10.1.2.3.6 Mexico Radioactive Tracer Market, by End-User

11. Radioactive Tracer Market Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Radioactive Tracer Market, Key Company Profiles

  • 12.1 Rotem Industries Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Invicro LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Cardinal Health Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Newcastle University
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Novartis AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Curium
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Blue Earth Diagnostics Limited
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 General Electric Co
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 IBA Radiopharma Solutions
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Radioactive Tracer Market Segmentation
  • Table 2. Principal Radionuclides Used in Radioactive Tracer
  • Table 3. US Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 4. US Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 5. US Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 6. US Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 7. Canada Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 8. Canada Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 9. Canada Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 10. Canada Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 11. Mexico Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 12. Mexico Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 13. Mexico Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 14. Mexico Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 15. Organic Developments Done by Companies
  • Table 16. Inorganic Developments Done by Companies
  • Table 17. Glossary of Terms, North America Radioactive Tracer Market

List Of Figures

  • Figure 1. North America Radioactive Tracer Market Segmentation, By Country
  • Figure 2. North America Radioactive Tracer Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • Figure 6. Technetium 99m and TC-97m: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Iodine 131: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Iron 59: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Lutetium- 171: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. RB82 and ammonia N-13: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Scandium 46: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Seaborgium-269: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Hassium -269: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Gallium Citrate GA 67: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. PSMA GA68: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. FDDNP (F-18) and FDOPA (f-18): North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Phosphorus 32 and Chromium -51: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Thallium-201: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. F-18 FDG: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. F-18 FAPI: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. GA 68 FAPI: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. F-18 PSMA: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 26. PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. SPECT: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. North America Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 30. Oncology: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pulmonary: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Neurology: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Cardiology: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Others: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. North America Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 36. Hospitals and Clinics: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Diagnostic Centers: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Academic and Research Institutes: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Others: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. North America Radioactive Tracer Market, by Country 2022 ($Mn)
  • Figure 41. North America Radioactive Tracer Market, By Key Countries, 2022 And 2030 (%)
  • Figure 42. US Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 43. Canada Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. Mexico Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)